5411 篇
13916 篇
478298 篇
16343 篇
11779 篇
3948 篇
6564 篇
1254 篇
75732 篇
38177 篇
12196 篇
1672 篇
2874 篇
3423 篇
642 篇
1242 篇
1980 篇
4929 篇
3895 篇
5517 篇
全球肝细胞癌治疗市场预测流行病学管道分析(2022-2027年)
Global Hepatocellular Carcinoma Treatment Market Forecast - Epidemiology Pipeline Analysis 2022-2027
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection, accounting for ~50% of cases.
CHAPTER – 1: HEPATOCELLULAR CARCINOMA OVERVIEW
CHAPTER – 2: HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW
CHAPTER - 3: HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW
CHAPTER – 4: HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW
CHAPTER – 5: HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW